Last update 30 Mar 2025

AlloCART-19(Children's Hospital of Fudan University)

Overview

Basic Info

Drug Type
Universal CAR-T
Synonyms
allogeneic CAR-T19
Target
CD19
Action
modulators
Mechanism
CD19 modulators(B-lymphocyte antigen CD19 modulators), Immunologic cytotoxicity, T lymphocyte replacements
Therapeutic Areas
NeoplasmsImmune System DiseasesHemic and Lymphatic Diseases+ [1]
Active Indication
Pre B-cell acute lymphoblastic leukemia
Inactive Indication-
Originator Organization
Paediatrics Hospital Affiliated To Fudan UniversityPaediatrics Hospital Affiliated To Fudan University
Active Organization
Paediatrics Hospital Affiliated To Fudan UniversityPaediatrics Hospital Affiliated To Fudan University
Inactive Organization-
Drug Highest PhaseEarly Phase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with AlloCART-19(Children's Hospital of Fudan University)
NCT04173988
/ Active, not recruitingEarly Phase 1IIT
A Single Center, Open Label, Single Arm Exploratory Clinical Study of CD19-Directed Allogeneic Chimeric Antigen Receptor CART-cell Immunotherapy Cell Therapy in Pediatric Patients With Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia
100 Clinical Results associated with AlloCART-19(Children's Hospital of Fudan University)
Login to view more data
100 Translational Medicine associated with AlloCART-19(Children's Hospital of Fudan University)
Login to view more data
100 Patents (Medical) associated with AlloCART-19(Children's Hospital of Fudan University)
Login to view more data
100 Deals associated with AlloCART-19(Children's Hospital of Fudan University)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Pre B-cell acute lymphoblastic leukemiaPhase 1
China
Paediatrics Hospital Affiliated To Fudan UniversityPaediatrics Hospital Affiliated To Fudan University
09 Jan 2020
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free